Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry ; volume:14 ; number:10 ; day:16 ; month:9 ; year:2024 ; pages:2805-2825 ; date:10.2024
Dermatology and therapy ; 14, Heft 10 (16.9.2024), 2805-2825, 10.2024
- Creator
-
Mease, Philip J.
Blauvelt, Andrew
Sima, Adam P.
Beaty, Silky W.
Low, Robert
Gomez, Braulio
Gurrola, Marie
Lebwohl, Mark G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-024-01258-1
- URN
-
urn:nbn:de:101:1-2501022156358.483580903912
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mease, Philip J.
- Blauvelt, Andrew
- Sima, Adam P.
- Beaty, Silky W.
- Low, Robert
- Gomez, Braulio
- Gurrola, Marie
- Lebwohl, Mark G.
- SpringerLink (Online service)
Other Objects (12)
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
Psoriasis and psoriatic arthritis : an integrated approach
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR)
Oral microbiota diversity in moderate to severe plaque psoriasis, nail psoriasis and psoriatic arthritis
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
Differences in oxylipin profile in psoriasis versus psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
Psoriasis and psoriatic arthritis : an integrated approach
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR)
Oral microbiota diversity in moderate to severe plaque psoriasis, nail psoriasis and psoriatic arthritis
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
Differences in oxylipin profile in psoriasis versus psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
Psoriasis and psoriatic arthritis : an integrated approach
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR)
Oral microbiota diversity in moderate to severe plaque psoriasis, nail psoriasis and psoriatic arthritis
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?